Alan So

8.3k total citations
200 papers, 5.3k citations indexed

About

Alan So is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Alan So has authored 200 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Pulmonary and Respiratory Medicine, 77 papers in Surgery and 65 papers in Molecular Biology. Recurrent topics in Alan So's work include Prostate Cancer Treatment and Research (56 papers), Bladder and Urothelial Cancer Treatments (54 papers) and Prostate Cancer Diagnosis and Treatment (47 papers). Alan So is often cited by papers focused on Prostate Cancer Treatment and Research (56 papers), Bladder and Urothelial Cancer Treatments (54 papers) and Prostate Cancer Diagnosis and Treatment (47 papers). Alan So collaborates with scholars based in Canada, United States and United Kingdom. Alan So's co-authors include Martin Gleave, Ladan Fazli, Palma Rocchi, Peter C. Black, Antonio Hurtado‐Coll, Eliana Beraldi, Boris Hadaschik, Ricardo Rendon, Fred Saad and Colleen C. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alan So

192 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan So Canada	43	2.2k	2.0k	1.4k	1.4k	866	200	5.3k
Yasutomo Nasu Japan	39	2.3k 1.1×	1.3k 0.6×	1.1k 0.8×	1.1k 0.8×	633 0.7×	295	5.4k
Robert H. Getzenberg United States	44	3.1k 1.4×	1.4k 0.7×	1.0k 0.7×	1.2k 0.8×	864 1.0×	172	5.9k
Robert J. Amato United States	43	1.9k 0.9×	2.1k 1.1×	2.1k 1.5×	1.2k 0.9×	826 1.0×	158	5.6k
Ganesh S. Palapattu United States	41	1.6k 0.8×	2.7k 1.3×	1.3k 0.9×	2.9k 2.1×	949 1.1×	185	6.5k
Hing Y. Leung United Kingdom	53	5.3k 2.4×	2.1k 1.1×	1.6k 1.1×	712 0.5×	1.8k 2.0×	204	7.8k
Daniel Fink Switzerland	45	3.1k 1.4×	613 0.3×	2.5k 1.8×	1.3k 0.9×	1.3k 1.5×	191	7.2k
Srikala S. Sridhar Canada	35	1.4k 0.6×	1.9k 1.0×	2.9k 2.0×	2.8k 2.0×	780 0.9×	314	6.1k
Louis Denis United States	29	1.2k 0.5×	2.4k 1.2×	2.0k 1.4×	2.3k 1.7×	500 0.6×	98	5.8k
Ronald Rodríguez United States	36	2.8k 1.3×	1.5k 0.8×	1.1k 0.7×	553 0.4×	520 0.6×	153	4.7k
Srinivasan Yegnasubramanian United States	52	6.3k 2.9×	3.8k 1.9×	1.6k 1.1×	709 0.5×	2.7k 3.1×	166	9.9k

Countries citing papers authored by Alan So

Since Specialization

Citations

This map shows the geographic impact of Alan So's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan So with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan So more than expected).

Fields of papers citing papers by Alan So

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan So. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan So. The network helps show where Alan So may publish in the future.

Co-authorship network of co-authors of Alan So

This figure shows the co-authorship network connecting the top 25 collaborators of Alan So. A scholar is included among the top collaborators of Alan So based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan So. Alan So is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

So, Alan, Kim Chi, Brita Danielson, et al.. (2025). 2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castrationsensitive prostate cancer (Update). Canadian Urological Association Journal. 19(5). E142–52.

Adomat, Hans, et al.. (2024). Evaluating different methods for kidney recellularization. Scientific Reports. 14(1). 23520–23520. 1 indexed citations

Guh, Daphne, Reka Pataky, Peter C. Black, et al.. (2023). Economic evaluation of prostate cancer risk assessment methods: A cost‐effectiveness analysis using population data. Cancer Medicine. 12(19). 20106–20118. 2 indexed citations

Bhindi, Bimal, Girish S. Kulkarni, D. Robert Siemens, et al.. (2021). Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version. Canadian Urological Association Journal. 15(8). 230–9. 9 indexed citations

Shiff, Benjamin, Rodney H. Breau, Ranjeeta Mallick, et al.. (2021). Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. Urologic Oncology Seminars and Original Investigations. 39(12). 836.e19–836.e27. 13 indexed citations

Malone, Shawn, Bobby Shayegan, Naveen S. Basappa, et al.. (2019). Management algorithms for metastatic prostate cancer. Canadian Urological Association Journal. 13(12). 50–60. 4 indexed citations

Nayan, Madhur, Anil Kapoor, Antonio Finelli, et al.. (2019). Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis. Urologic Oncology Seminars and Original Investigations. 37(9). 576.e11–576.e16. 2 indexed citations

Wong, Emily C L, Rodney H. Breau, Frédéric Pouliot, et al.. (2019). Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2. Urologic Oncology Seminars and Original Investigations. 37(10). 721–726. 23 indexed citations

Saad, Fred, Neil Fleshner, Alan So, et al.. (2018). The burden of symptomatic skeletal events in castrate-resistant prostate cancer patients with bone metastases at three Canadian uro-oncology centres. Canadian Urological Association Journal. 12(12). 370–376. 5 indexed citations

10.

Frees, Sebastian, Jonathan Aning, Peter C. Black, et al.. (2017). A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer. World Journal of Urology. 36(2). 215–220. 62 indexed citations

11.

Richard, Patrick O., Philippe D. Violette, Michael A.S. Jewett, et al.. (2017). CUA guideline on the management of cystic renal lesions. Canadian Urological Association Journal. 11(3-4). 66–66. 27 indexed citations

12.

Han, Kyung Seok, Na Li, Peter A. Raven, et al.. (2015). Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 14(4). 1024–1034. 24 indexed citations

13.

Abdi, Hamidreza, Farshad Pourmalek, Homayoun Zargar, et al.. (2015). Multiparametric Magnetic Resonance Imaging Enhances Detection of Significant Tumor in Patients on Active Surveillance for Prostate Cancer. Urology. 85(2). 423–429. 43 indexed citations

14.

Abdi, Hamidreza, Homayoun Zargar, S. Larry Goldenberg, et al.. (2015). Multiparametric magnetic resonance imaging–targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results. Urologic Oncology Seminars and Original Investigations. 33(4). 165.e1–165.e7. 31 indexed citations

15.

Han, Kyung Seok, Na Li, Ladan Fazli, et al.. (2015). Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway. Oncotarget. 6(33). 34818–34830. 16 indexed citations

16.

Kapoor, Anil, Louis Girard, Jean‐Baptiste Lattouf, et al.. (2015). Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML). Urology. 89. 19–26. 18 indexed citations

17.

Nickel, J. Curtis, Joe Downey, François Bénard, et al.. (2013). The Canadian Benign Prostatic Hyperplasia Audit Study (CanBas). Canadian Urological Association Journal. 2(4). 367–367. 4 indexed citations

18.

Mugabe, Clement, Yoshiyuki Matsui, Alan So, et al.. (2011). In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 17(9). 2788–2798. 51 indexed citations

19.

Narita, Shintaro, Alan So, Susan Ettinger, et al.. (2008). GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer. Clinical Cancer Research. 14(18). 5769–5777. 56 indexed citations

20.

Trougakos, Ioannis P., Alan So, Burkhard Jansen, Martin Gleave, & Efstathios S. Gonos. (2004). Silencing Expression of the Clusterin/Apolipoprotein J Gene in Human Cancer Cells Using Small Interfering RNA Induces Spontaneous Apoptosis, Reduced Growth Ability, and Cell Sensitization to Genotoxic and Oxidative Stress. Cancer Research. 64(5). 1834–1842. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact